SYNGAP antisense oligonucleotide (Quiver Bioscience)

N/A

Report date: 2025/06/27 16:57:39
NME

Base Information

Drug NameSYNGAP antisense oligonucleotide (Quiver Bioscience)
Drug Alias NameSYNGAP (ASO)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRas/Rap GTPase-activating protein SynGAP modulators
TargetsRas/Rap GTPase-activating protein SynGAP
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuiver Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuiver Bioscience Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A